Therapeutic preferences and factors determining the use of inhaled corticosteroids with long-acting β(2)-agonists in patients with asthma and chronic obstructive pulmonary disease

INTRODUCTION: Inhaled corticosteroids (ICS) and long-acting β(2)-agonists (LABA) are a part of standard therapy of bronchial asthma and chronic obstructive pulmonary disease (COPD). AIM: Assessment of the therapeutic preferences and factors determining the choice of polytherapy with ICS and LABA in...

Descripción completa

Detalles Bibliográficos
Autores principales: Olszanecka-Glinianowicz, Magdalena, Chudek, Jerzy, Almgren-Rachtan, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610065/
https://www.ncbi.nlm.nih.gov/pubmed/34849120
http://dx.doi.org/10.5114/ada.2020.99945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610065/
https://www.ncbi.nlm.nih.gov/pubmed/34849120
http://dx.doi.org/10.5114/ada.2020.99945

Ejemplares similares